Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Marco Boeri, Boglarka Szegvari, Brett Hauber, Brennan Mange, Irina Mountian, Michael Schiff & Nikolaos Maniadakis. (2019) From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices. Patient Preference and Adherence 13, pages 1093-1110.
Read now
Read now
Mark L. Warren, Meryl Brod, Jonas Håkan-Bloch, Thomas Sparre & Louis B. Chaykin. (2019) Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes. Current Medical Research and Opinion 35:9, pages 1623-1629.
Read now
Read now
Toshinari Asakura, Shuichi Suzuki, Toshihiko Aranishi & Zhihong Cai. (2018) Comparative usability study of the dulaglutide single-use pen versus the insulin degludec FlexTouch® among self-injection-naïve patients with type 2 diabetes mellitus in Japan. Current Medical Research and Opinion 34:6, pages 1117-1124.
Read now
Read now
Andreas E. Schneider & Jakob Lange. (2018) Pen devices for self-injection: contrasting measured injection force with users’ perceived ease of injection. Expert Opinion on Drug Delivery 15:2, pages 115-125.
Read now
Read now
Barbara Domańska, Brenda VanLunen, Luke Peterson, Irina Mountian & Michael Schiff. (2017) Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis. Expert Opinion on Drug Delivery 14:1, pages 15-22.
Read now
Read now
Andreas Pfützner, Thomas Forst, Marcus Niemeyer & Timothy Bailey. (2014) Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals. Expert Opinion on Drug Delivery 11:9, pages 1381-1389.
Read now
Read now
Dorte Götzche, Bo Ølgaard Rasmussen, Michael Torben Pedersen, Thomas Sparre, Ditlef Bucher & Marcus Niemeyer. (2013) Injection force and dose accuracy of FlexTouch for the delivery of a new basal insulin. Expert Opinion on Drug Delivery 10:12, pages 1613-1619.
Read now
Read now
Rosemarie Lajara, German Guerrero & Jerome Thurman. (2012) Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe. Expert Opinion on Drug Delivery 9:10, pages 1181-1196.
Read now
Read now
David Oyer, Marcus Niemeyer & Alan Moses. (2012) Empowering People with Diabetes: Improving Perceptions and Outcomes with Technical Advances in Insulin Pens. Postgraduate Medicine 124:5, pages 110-120.
Read now
Read now
Carlos Campos, Rosemarie Lajara & Tony Deluzio. (2012) Usability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nurses. Expert Opinion on Pharmacotherapy 13:13, pages 1837-1846.
Read now
Read now
Christina Schipper, Petra Musholt, Marcus Niemeyer, Marianne Qvist, Andrea Löffler, Thomas Forst & Andreas Pfützner. (2012) Patient device assessment evaluation of two insulin injection devices in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitus. Current Medical Research and Opinion 28:8, pages 1297-1303.
Read now
Read now
Articles from other publishers (14)
Małgorzata Masierek, Katarzyna Nabrdalik, Oliwia Janota, Hanna Kwiendacz, Maksymilian Macherski & Janusz Gumprecht. (2022) The Review of Insulin Pens—Past, Present, and Look to the Future. Frontiers in Endocrinology 13.
Crossref
Crossref
Arvind GuptaSanjeev PhatakY. Sadashiv RaoJayanthy Ramesh & Debmalya Sanyal. (2020) Consensus on Choice of Insulin Pen Devices in Routine Clinical Practice in India. Diabetes Technology & Therapeutics 22:10, pages 777-786.
Crossref
Crossref
Louis S. Matza, Kristina S. Boye, Katie D. Stewart, Karin S. Coyne, Paula K. Wullenweber, Katelyn N. Cutts, Jessica B. Jordan, Qianqian Wang, Maria Yu, Brooke M. Currie, Karen G. Malley, K. Jack Ishak, Ryan T. Hietpas & Luis‐Emilio García‐Pérez. (2019) Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER). Diabetes, Obesity and Metabolism 22:3, pages 355-364.
Crossref
Crossref
Lalantha Leelarathna, Donna Ashley, Carrie Fidler & Witesh Parekh. (2018) The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective. Therapeutic Advances in Endocrinology and Metabolism 9:7, pages 187-197.
Crossref
Crossref
Barbara Domańska, Oliver Stumpp, Steven Poon, Serkan Oray, Irina Mountian & Clovis Pichon. (2017) Using Patient Feedback to Optimize the Design of a Certolizumab Pegol Electromechanical Self-Injection Device: Insights from Human Factors Studies. Advances in Therapy 35:1, pages 100-115.
Crossref
Crossref
Niels GudiksenThibaud HofstätterBirgitte B. RønnThomas Sparre. (2017) FlexTouch: An Insulin Pen-Injector with a Low Activation Force Across Different Insulin Formulations, Needle Technologies, and Temperature Conditions. Diabetes Technology & Therapeutics 19:10, pages 603-607.
Crossref
Crossref
Colin H. Ridyard, Dalia M. M. Dawoud, Lorna V. Tuersley & Dyfrig A. Hughes. (2016) A Systematic Review of Patients’ Perspectives on the Subcutaneous Route of Medication Administration. The Patient - Patient-Centered Outcomes Research 9:4, pages 281-292.
Crossref
Crossref
Ken Fujioka, Thomas Sparre, Lily Yong-Hui Sun, Susanne Krogsgaard & Robert F. Kushner. (2015) Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience. Journal of Diabetes Science and Technology 10:1, pages 164-174.
Crossref
Crossref
Morihiro Okada, Masae Okada, Jun Nishigami, Naoto Yamaaki, Kenji Furukawa, Kiminori Ohyama, Tsutomu Shimada & Yoshimichi Sai. (2015) Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus. Journal of Pharmaceutical Health Care and Sciences 1:1.
Crossref
Crossref
Lori Berard & Gail MacNeill. (2015) Insulin Degludec, a Long-Acting Once-Daily Basal Analogue for Type 1 and Type 2 Diabetes Mellitus. Canadian Journal of Diabetes 39:1, pages 4-9.
Crossref
Crossref
Hitomi Fujii, Mikako Baba, Takayuki Mori, Yoshiko Asada, Akihito Nonaka, Yuko Watanabe, Yoshiaki Kawagoe, Miyuki Nogawa, Takaichi Miyakawa & Masafumi Kitaoka. (2014) Practical Experience With a New Prefilled Pen Device for a Long-Acting Insulin Analog in Japan. Journal of Diabetes Science and Technology 8:4, pages 904-905.
Crossref
Crossref
Athena Philis-Tsimikas, Meryl Brod, Marcus Niemeyer, Ann Marie Ocampo Francisco & Jeffrey Rothman. (2013) Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use). Advances in Therapy 30:6, pages 607-622.
Crossref
Crossref
Andreas Pfützner, Christina Schipper, Marcus Niemeyer, Marianne Qvist, Andrea Löffler, Thomas Forst & Petra B. Musholt. (2012) Comparison of Patient Preference for Two Insulin Injection Pen Devices in Relation to Patient Dexterity Skills. Journal of Diabetes Science and Technology 6:4, pages 910-916.
Crossref
Crossref
Timothy S. Bailey. (2012) Analysis and Perspective: Comparison of Insulin Diluent Leakage Post-Injection Using Two Different Needle Lengths and Injection Volumes in Obese Patients with Type 1 or Type 2 Diabetes Mellitus. Journal of Diabetes Science and Technology 6:2, pages 394-395.
Crossref
Crossref